Wordt geladen...
Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
Major progress in cancer immunotherapies have been obtained by the use of tumor targeting strategies, in particular with the development of bi-functional fusion proteins such as ImmTacs or BiTes, which engage effector T cells for targeted elimination of tumor cells. Given the significance of invaria...
Bewaard in:
| Gepubliceerd in: | Front Immunol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5672503/ https://ncbi.nlm.nih.gov/pubmed/29163493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01417 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|